Simone Guerrieri

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Journal: Neurology

Published: November 24, 2025

Unveiling a silent threat: slowly expanding spinal cord lesion linked to clinical worsening in multiple sclerosis: a case report.

Unveiling a silent threat: slowly expanding spinal cord lesion linked to clinical worsening in multiple sclerosis: a case report.

Journal: Journal of neurology

Published: October 02, 2025

Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use.

Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use.

Journal: Journal of neurology

Published: July 02, 2025

Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study.

Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study.

Journal: Journal of neurology

Published: April 17, 2025

Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter?

Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter?

Journal: Journal of neurology

Published: August 27, 2024

Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics.

Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics.

Journal: Brain, behavior, and immunity

Published: April 09, 2024

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.

Journal: European journal of neurology

Published: March 06, 2024

Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series.

Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series.

Journal: Journal of neurology

Published: February 14, 2024

Fast but not furious: Rapid ocrelizumab infusion as a strategy to optimize multiple sclerosis patients' management.

Fast but not furious: Rapid ocrelizumab infusion as a strategy to optimize multiple sclerosis patients' management.

Journal: Journal of the neurological sciences

Published: November 15, 2023

Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis.

Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis.

Journal: Brain communications

Published: May 22, 2023

Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience.

Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience.

Journal: European journal of neurology

Published: February 23, 2023

Intensive Neurorehabilitation and Gait Improvement in Progressive Multiple Sclerosis: Clinical, Kinematic and Electromyographic Analysis.

Intensive Neurorehabilitation and Gait Improvement in Progressive Multiple Sclerosis: Clinical, Kinematic and Electromyographic Analysis.

Journal: Brain sciences

Published: December 13, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026